Kenneth J. Zuerblis, EVP, Chief Financial Officer at SAVIENT PHARMACEUTICALS INC (SVNT), bought 5,000 shares at $4.05 ($20K) on 2011-09-15, disclosed to the SEC on 2011-09-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.97 | 1,000 | $4K | 19.7% |
| 2 | $4.05 | 4,000 | $16K | 80.3% |
| Total | $4.03 avg | 5,000 | $20K | 100% |
| Filing → |
| SVNT | BUY | 2011-11-21 | $5K | — | Filing → |